<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156449">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01975792</url>
  </required_header>
  <id_info>
    <org_study_id>817255</org_study_id>
    <nct_id>NCT01975792</nct_id>
  </id_info>
  <brief_title>Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes</brief_title>
  <acronym>TIPS</acronym>
  <official_title>Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcome in Women at High Risk for Preterm Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The thymus gland is a specialized organ in the chest that plays a central role in the
      adaptive immune system throughout development until puberty. In response to stress, the
      fetal thymus gland may shrink, or involute. The investigators propose a prospective cohort
      study that will enroll pregnant women admitted to labor and delivery for the management of
      preterm labor and/or preterm premature rupture of membranes from 28-36 weeks gestation.
      Based on sonographic thymus measurements, the investigators will develop a clinical
      prediction tool to identify babies who are at increased risk for adverse neonatal outcomes.
      A reliable non-invasive predictor of adverse neonatal outcome using thymic ultrasound
      measurements has the potential to affect clinical management, improve outcomes for premature
      babies, and direct further research efforts.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Respiratory Distress</measure>
    <time_frame>Date of delivery up to 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Neonatal respiratory compromise defined as respiratory distress requiring any CPAP (continuous positive airway pressure) and or ventilator therapy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Women Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)</condition>
  <arm_group>
    <arm_group_label>Preterm Admits</arm_group_label>
    <description>Women who are admitted for preterm labor observation and management</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant patients with singleton pregnancies admitted to labor and delivery at the
        Hospital of the University of Pennsylvania between 28-36 weeks gestation for the
        management of spontaneous preterm labor (defined as uterine contractions and documented
        cervical change) and/or preterm premature rupture of membranes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancy between 28-36 weeks gestation

          -  Active spontaneous preterm labor symptoms (contractions, cervical dilatation and/or
             PPROM)

        Exclusion Criteria:

          -  Non-singleton pregnancies

          -  Gestational hypertension/preeclampsia

          -  Major fetal anomalies

          -  Known fetal aneuploidy

          -  Intrauterine Fetal Demise
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadav Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nadav Schwartz, MD</last_name>
    <phone>(215) 615-4358</phone>
    <email>SchwartN@obgyn.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Justin Brandt, MD</last_name>
    <email>Justin.Brandt@uphs.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Brandt, MD</last_name>
      <email>Justin.Brandt@uphs.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brittany Araujo, BS</last_name>
      <phone>215-615-6047</phone>
      <email>OBResearch@uphs.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nadav Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 28, 2013</lastchanged_date>
  <firstreceived_date>September 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Nadav Schwartz</investigator_full_name>
    <investigator_title>Assistant Professor, Hospital of the University of Pennsylvania</investigator_title>
  </responsible_party>
  <keyword>PPROM</keyword>
  <keyword>Pregnant</keyword>
  <keyword>Preterm</keyword>
  <keyword>Premature, labor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
